SEC Form 4 · accession 0001209191-16-137013
CYNOSURE INC · CYNO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael R Davin
Officer — Chairman, President and CEO · Director
Period of report
Aug 11, 2016
Accepted (ET)
Aug 15, 2016 · 4:47 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000885306
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock | Aug 11, 2016 | M | 4,222 | $30.51 | A | 4,222 | D | |
| Class A Common StockF2 | Aug 11, 2016 | S | 4,222 | $53.1833 | D | 0 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F3 | $30.51 | Aug 11, 2016 | M | 4,222 | D | — | Feb 11, 2025 | Class A Common Stock | 4,222 | 25,330 | D |
Explanation of responses
- F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- F2The sales price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $52.86 to $53.68 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
- F3The option became exercisable as to approximately 8.33% of the shares on each three-month anniversary of the 2/11/2015 grant date.